No abstract available
Keywords:
aging; atrial fibrillation; comorbidities; health; prevention.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Action Potentials
-
Age Factors
-
Atrial Fibrillation / complications*
-
Atrial Fibrillation / diagnosis
-
Atrial Fibrillation / drug therapy
-
Atrial Fibrillation / physiopathology
-
Cerebrovascular Disorders / diagnosis
-
Cerebrovascular Disorders / etiology*
-
Cerebrovascular Disorders / prevention & control
-
Cerebrovascular Disorders / psychology
-
Cognition*
-
Cognitive Dysfunction / diagnosis
-
Cognitive Dysfunction / etiology*
-
Cognitive Dysfunction / prevention & control
-
Cognitive Dysfunction / psychology
-
Cross-Sectional Studies
-
Factor Xa Inhibitors / therapeutic use
-
Female
-
Heart Conduction System / physiopathology*
-
Heart Rate*
-
Humans
-
Male
-
Middle Aged
-
Pilot Projects
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Risk Factors
-
Rivaroxaban / therapeutic use
Substances
-
Factor Xa Inhibitors
-
Rivaroxaban